Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial-Reference-Cited by-同舟云学术

Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial

Published:2024-05 Issue: Volume:194 Page:110160
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Fiorino C.,Palumbo D.,Mori M.,Palazzo G.,Pellegrini A.E.,Albarello L.,Belardo A.,Canevari C.,Cossu A.,Damascelli A.,Elmore U.,Mazza E.,Pavarini M.,Passoni P.,Puccetti F.,Slim N.,Steidler S.,Del Vecchio A.,Di Muzio N.G.,Chiti A.,Rosati R.,De Cobelli F.

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Reference42 articles.

1. CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;The New England Journal of Medicine,2012

2. CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;The Lancet Oncology,2015

3. D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS et al. International Esodata Study Group. Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001/jamasurg.2021.2376. Erratum in: JAMA Surg. 2021;156(9):894.

4. Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis;Park;Radiation Oncology,2021

5. Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study;van der Wilk;Annals of Surgery,2021